Kwizera Richard, Kiiza Tadeo K, Akampurira Andrew, Kimuda Sarah, Mugabi Timothy, Meya David B
Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Open Forum Infect Dis. 2024 Aug 27;11(9):ofae487. doi: 10.1093/ofid/ofae487. eCollection 2024 Sep.
Cryptococcal meningitis is one of the leading causes of death in sub-Saharan Africa among patients with advanced HIV disease. Early diagnosis is crucial in improving treatment outcomes. Despite advances and the availability of modern and point-of-care diagnostics for cryptococcosis, gaps still exist in resource-constrained settings, leading to unfavorable treatment outcomes. Here, we review the current outstanding issues or missing links that need to be filled to optimize the diagnosis of cryptococcosis in resource-constrained settings to improve treatment outcomes. We highlight the evolution of cryptococcosis diagnostics; the roles of early fungicidal activity, cryptococcal antigen titers, antifungal susceptibility testing, and therapeutic drug monitoring; and the missing links to optimize diagnosis and outcomes, including practical recommendations.
隐球菌性脑膜炎是撒哈拉以南非洲地区晚期艾滋病患者的主要死因之一。早期诊断对于改善治疗效果至关重要。尽管在隐球菌病的现代即时诊断方面取得了进展且已有相关诊断方法,但在资源有限的环境中仍存在差距,导致治疗效果不佳。在此,我们回顾当前在资源有限环境中优化隐球菌病诊断以改善治疗效果所需填补的突出问题或缺失环节。我们强调隐球菌病诊断的演变;早期杀菌活性、隐球菌抗原滴度、抗真菌药敏试验和治疗药物监测的作用;以及优化诊断和治疗效果的缺失环节,包括实际建议。